Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatment.
Braas D, Ahler E, Tam B, Nathanson D, Riedinger M, Benz MR, Smith KB, Eilber FC, Witte ON, Tap WD, Wu H, Christofk HR.
Braas D, et al. Among authors: tap wd.
Cancer Discov. 2012 Dec;2(12):1109-17. doi: 10.1158/2159-8290.CD-12-0197.
Cancer Discov. 2012.
PMID: 23230188
Free PMC article.